Form D · Biotechnology

Hamilton Thorne, Inc.

Beverly, MA · CIK 0001347809

Offering snapshot reported Nov 6, 2009 · SEC filing

Reported sold
$2.08M
Offering amount: $2.08M
Investors reported
11
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Oct 28, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 6, 2009Initial$2,075,472No comparison11SEC filing
Jan 19, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Dec 21, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
Yes
Sales commissions
$128K
Finders' fees
$0
Form D file number
021-84358
Commission is equal to 8% of $1,603,774 of the gross proceeds raised pursuant to the offering; also received warrants

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Loewen, Ondaatje, McCutcheon Limited35205

Source: Form D, filed Nov 6, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew D Clapp Director
Diarmaid Douglas Hamilton Director, Executive
Harry G Mc Coy Director
Scott Pearson Director
Robert J Potter Director
Meg Spencer Director, Executive
Daniel K Thorne Director
David Wolf Executive
Louisa Wood Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
100 Cummings Center Ste 465 E
Beverly, MA, 01915